225 related articles for article (PubMed ID: 18356312)
1. Health technology assessment in the cost-disutility plane.
Eckermann S; Briggs A; Willan AR
Med Decis Making; 2008; 28(2):172-81. PubMed ID: 18356312
[TBL] [Abstract][Full Text] [Related]
2. Complementing the net benefit approach: a new framework for Bayesian cost-effectiveness analysis.
Hernández MA; Vázquez-Polo FJ; González-Torre FJ; Bas EM
Int J Technol Assess Health Care; 2009 Oct; 25(4):537-45. PubMed ID: 19845984
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness acceptability curves--caveats quantified.
Jakubczyk M; Kamiński B
Health Econ; 2010 Aug; 19(8):955-63. PubMed ID: 19688780
[TBL] [Abstract][Full Text] [Related]
4. Expected value of information and decision making in HTA.
Eckermann S; Willan AR
Health Econ; 2007 Feb; 16(2):195-209. PubMed ID: 16981193
[TBL] [Abstract][Full Text] [Related]
5. Presenting evidence and summary measures to best inform societal decisions when comparing multiple strategies.
Eckermann S; Willan AR
Pharmacoeconomics; 2011 Jul; 29(7):563-77. PubMed ID: 21671686
[TBL] [Abstract][Full Text] [Related]
6. Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis.
Groot Koerkamp B; Hunink MG; Stijnen T; Hammitt JK; Kuntz KM; Weinstein MC
Med Decis Making; 2007; 27(2):101-11. PubMed ID: 17409361
[TBL] [Abstract][Full Text] [Related]
7. Including quality attributes in efficiency measures consistent with net benefit: creating incentives for evidence based medicine in practice.
Eckermann S; Coelli T
Soc Sci Med; 2013 Jan; 76(1):159-68. PubMed ID: 23153543
[TBL] [Abstract][Full Text] [Related]
8. Incremental cost-effectiveness ratio and incremental net-health benefit: two sides of the same coin.
Craig BA; Black MA
Expert Rev Pharmacoecon Outcomes Res; 2001 Oct; 1(1):37-46. PubMed ID: 19807506
[TBL] [Abstract][Full Text] [Related]
9. Modeling the value for money of changing clinical practice change: a stochastic application in diabetes care.
Hoomans T; Abrams KR; Ament AJ; Evers SM; Severens JL
Med Care; 2009 Oct; 47(10):1053-61. PubMed ID: 19648827
[TBL] [Abstract][Full Text] [Related]
10. Identifying key parameters in cost-effectiveness analysis using value of information: a comparison of methods.
Groot Koerkamp B; Myriam Hunink MG; Stijnen T; Weinstein MC
Health Econ; 2006 Apr; 15(4):383-92. PubMed ID: 16389669
[TBL] [Abstract][Full Text] [Related]
11. Making health technology assessment information available for decision making: the development of a Thai database.
Kapol N; Maitreemit P; Chalongsuk R; Amrumpai Y; Sribundit N; Thavorncharoensap M; Chaikledkaew U; Teerawattananon Y
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S8-10. PubMed ID: 19253482
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis and formulary decision making in England: findings from research.
Williams IP; Bryan S
Soc Sci Med; 2007 Nov; 65(10):2116-29. PubMed ID: 17698271
[TBL] [Abstract][Full Text] [Related]
13. Health system and equity perspectives in health technology assessment.
Hanvoravongchai P
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S74-87. PubMed ID: 19253490
[TBL] [Abstract][Full Text] [Related]
14. Better informing decision making with multiple outcomes cost-effectiveness analysis under uncertainty in cost-disutility space.
McCaffrey N; Agar M; Harlum J; Karnon J; Currow D; Eckermann S
PLoS One; 2015; 10(3):e0115544. PubMed ID: 25751629
[TBL] [Abstract][Full Text] [Related]
15. Classification of evidence in decision-analytic models of cost-effectiveness: a content analysis of published reports.
Paisley S
Int J Technol Assess Health Care; 2010 Oct; 26(4):458-62. PubMed ID: 20923588
[TBL] [Abstract][Full Text] [Related]
16. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
17. The option value of delay in health technology assessment.
Eckermann S; Willan AR
Med Decis Making; 2008; 28(3):300-5. PubMed ID: 18480035
[TBL] [Abstract][Full Text] [Related]
18. Measurement of clinical effects.
Teerawattananon Y; Thavorncharoensap M; Mohara A
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S38-42. PubMed ID: 19253486
[TBL] [Abstract][Full Text] [Related]
19. Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables.
Baltussen RM; Hutubessy RC; Evans DB; Murray CJ
Int J Technol Assess Health Care; 2002; 18(1):112-9. PubMed ID: 11987434
[TBL] [Abstract][Full Text] [Related]
20. Presenting results of probabilistic sensitivity analysis: the incremental benefit curve.
Bala MV; Zarkin GA; Mauskopf J
Health Econ; 2008 Mar; 17(3):435-40. PubMed ID: 17694580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
